| Emily Rebecca Woodson, SLP | |
|
1900 Aldersgate Rd, Little Rock, AR 72205-6620 | |
| (501) 821-5459 | |
| Not Available |
| Full Name | Emily Rebecca Woodson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1900 Aldersgate Rd, Little Rock, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013678382 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Rebecca Woodson, SLP 1900 Aldersgate Rd, Little Rock, AR 72205-6620 Ph: (501) 821-5459 | Emily Rebecca Woodson, SLP 1900 Aldersgate Rd, Little Rock, AR 72205-6620 Ph: (501) 821-5459 |
News Archive
Roche and Chiasma Inc., a privately held biopharma company, announced today that they have entered into an agreement to develop and commercialize Chiasma's proprietary product Octreolin, initially for acromegaly and subsequently for neuroendocrine tumors.
Zimmer Holdings, Inc., a global leader in musculoskeletal care, announced today that the Trabecular Metal Modular Cup has received the distinction of being awarded the highest reimbursement premium percentage granted to-date for an orthopaedic product in Japan.
GlycoVaxyn, a pioneer in the development of innovative bioconjugate vaccines, has commenced a Phase I clinical study with its vaccine candidate (GVXN SD133) against Shigella dysenteriae, a cause of serious intestinal infections. This is the first product from the company to enter clinical evaluation.
Urologists at University of California, San Diego School of Medicine and Genesis Healthcare Partners have tested a new model of care for patients with low-risk prostate cancer. The evidence-based approach uses best practices to appropriately select and follow patients to avoid disease overtreatment. Results of the three-year study are now published online in the journal of Urology.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
› Verified 1 days ago
All Children's Therapy, Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10201 W Markham St # 216, Little Rock, AR 72205 Phone: 501-772-7771 Fax: 501-694-9463 | |
Laura Dickson, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9720 N Rodney Parham Rd, Little Rock, AR 72227 Phone: 501-228-3808 | |
Ms. Marcia Roles Bingham, MS.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11517 Kanis Rd, Little Rock, AR 72211 Phone: 501-993-8707 Fax: 501-223-8075 | |
Jessica Letzig Berkow, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1900 Aldersgate Rd, Little Rock, AR 72205 Phone: 501-821-6116 | |
Brooke Harris, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3920 Woodland Heights Rd, Little Rock, AR 72212 Phone: 501-227-3600 Fax: 501-227-4021 | |
Mrs. Tracy Bair Pate, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Way, Little Rock, AR 72202 Phone: 501-364-6688 Fax: 501-364-6646 | |
Kaylee Pickle, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1900 Aldersgate Rd, Little Rock, AR 72205 Phone: 501-227-0434 |